FORM 6-K
 

 

SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
 


For period ending December 2009
 

GlaxoSmithKline plc
(Name of registrant)
 
 

 

980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)
 
 

Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F
 
 

Form 20-F x Form 40-F
 

 --

Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
 
 
Yes No x
  --

 
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons


I give below details of changes 
in interests in the Ordinary share 
ADRs
 of GlaxoSmithKline plc in respect of the under-mentioned person, arising
 from 
the sale
 of 
Ordinary share ADRs
 
on 
28 September
 2009 
at a price of $39.70
per ADR:

Mrs S Burns             

                                     95



The Company and 
the above named person was
 advised of this information 
on 
16
 December
 2009.

This notification relates to a transaction notified in accordance with
Disclosure 
and Transparency 
Rule 3.1.4R(1)(a).

S M Bicknell
Company Secretary

18
 December
 
2009

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
 

GlaxoSmithKline plc
(Registrant)
 
 

Date: December 18, 2009

By: VICTORIA WHYTE

------------------

Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc